Your browser doesn't support javascript.
loading
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Berrien-Elliott, Melissa M; Becker-Hapak, Michelle; Cashen, Amanda F; Jacobs, Miriam; Wong, Pamela; Foster, Mark; McClain, Ethan; Desai, Sweta; Pence, Patrick; Cooley, Sarah; Brunstein, Claudio; Gao, Feng; Abboud, Camille N; Uy, Geoffrey L; Westervelt, Peter; Jacoby, Meagan A; Pusic, Iskra; Stockerl-Goldstein, Keith E; Schroeder, Mark A; DiPersio, John F; Soon-Shiong, Patrick; Miller, Jeffrey S; Fehniger, Todd A.
Afiliação
  • Berrien-Elliott MM; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Becker-Hapak M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Cashen AF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Jacobs M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Wong P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Foster M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • McClain E; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Desai S; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Pence P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Cooley S; Department of Medicine, University of Minnesota, Minneapolis, MN.
  • Brunstein C; Department of Medicine, University of Minnesota, Minneapolis, MN.
  • Gao F; Department of Surgery, Washington University School of Medicine, St. Louis, MO.
  • Abboud CN; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Uy GL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Westervelt P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Jacoby MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Pusic I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Stockerl-Goldstein KE; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Schroeder MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • Soon-Shiong P; ImmunityBio Inc., Culver City, CA; and.
  • Miller JS; Department of Surgery, University of California, Los Angeles, CA.
  • Fehniger TA; Department of Medicine, University of Minnesota, Minneapolis, MN.
Blood ; 139(8): 1177-1183, 2022 02 24.
Article em En | MEDLINE | ID: mdl-34797911

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Células Matadoras Naturais / Leucemia Mieloide Aguda / Imunoterapia Adotiva / Transplante de Células-Tronco Hematopoéticas / Linfócitos T CD8-Positivos / Interleucina-15 / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Macau

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Células Matadoras Naturais / Leucemia Mieloide Aguda / Imunoterapia Adotiva / Transplante de Células-Tronco Hematopoéticas / Linfócitos T CD8-Positivos / Interleucina-15 / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Macau